CIRM Improves Openness, Provides More Timely, Significant Information for Directors Meeting
For the second time in a row, the California stem cell agency is providing the public -- in a timely fashion -- with substantial background information on matters to be decided at an upcoming meeting of its board of directors.
The latest session comes next week (Oct. 26). Among other things, directors are scheduled to approve a $30 million, business-fri…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.